« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 13, Issue 7
, Pages 872-874
, July 2007
Treatment of Severe Hemorrhagic Cystitis after Allogeneic Stem Cell Transplantation with Palifermin, a Recombinant Human Keratinocyte Growth Factor
References
- Acute bleeding after bone marrow transplantation (BMT)—incidence and effect on survival (A quantitative analysis in 1,402 patients). Blood. 1998;91:1469–1477
- Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood. 2004;103:4674–4680
- . Hemorrhagic cystitis: a review. J Urol. 1990;143:1–9
- Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32:903–907
- . Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 1989;245:752–755
- Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:797–804
- . BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist. J Clin Virol. 2003;26:71–77
- . Hemorrhagic cystitis after bone marrow transplantation (Risk factors and complications). Transplantation. 1993;56:875–879
- Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation. 2000;70:1807–1811
- Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis. Cancer Res. 1997;57:472–475
PII: S1083-8791(07)00238-8
doi: 10.1016/j.bbmt.2007.04.002
© 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 13, Issue 7
, Pages 872-874
, July 2007
